SPAC Overview
Timeline Progress
- Registration2020-09-21 Filed S1
- IPO2021-01-27 IPO, search begins
- Definitive AgreementNo merger agreement yet
- Failed2023-02-02 Failed
About
Biotech Acquisition Company is a blank-check company formed to complete an initial business combination. It expects to focus on healthcare, particularly life sciences/biotechnology, healthcare IT, medical technology and technology-enabled healthcare services, including platform biotech and B2B digital-health enterprise solutions.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
United States, other developed countries
The terms and the filing trail behind Biotech Acquisition Co
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team is affiliated with SPRIM Global Investments, a life-sciences investment firm and global CRO/advisory business. Its leadership includes SPRIM co-founders and executives with healthcare, biotechnology, digital-health, investment, clinical-trial and operating experience; it has also partnered with Tikehau Capital on life-sciences venture funds.